PNC Financial Services Group
PASG icon

PNC Financial Services Group’s Passage Bio PASG Stock Holding History

PNC Financial Services Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-50
Closed -$10K – 4575
2021
Q3 		$10K Buy
+50
New +$11.9K ﹤0.01% 3754

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group's PASG Position: Q4 2021 in Review

PNC Financial Services Group sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 50 shares — an estimated $10K sold.

PNC Financial Services Group first reported a position in PASG in Q3 2021 and held it in 1 quarter. The position peaked at $10K in Q3 2021. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

  • PNC Financial Services Group reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 50 Passage Bio shares in Q4 2021, an estimated $10K.
  • PNC Financial Services Group first reported a position in Passage Bio in Q3 2021 and held it in 1 quarter.
  • PNC Financial Services Group's Passage Bio position peaked at $10K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.